CHARINALE PRADO: Open Payments
NPI 1700212271 · FLAGSTAFF, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,839 in 150 payments from 46 companies in 2025. Trend: 2023 $3,967 · 2024 $3,025 · 2025 $3,839
Food & beverage: $3,563Education: $276
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $427 |
| Janssen Biotech, Inc. | 12 | $285 |
| PFIZER INC. | 13 | $255 |
| E.R. Squibb & Sons, L.L.C. | 8 | $168 |
| Lilly USA, LLC | 6 | $165 |
| Merck Sharp & Dohme LLC | 6 | $165 |
| GlaxoSmithKline, LLC. | 7 | $154 |
| Aveo Pharmaceuticals, Inc. | 4 | $150 |
| ABBVIE INC. | 6 | $147 |
| Daiichi Sankyo Inc. | 5 | $136 |
Products named: KEYTRUDA, FOTIVDA, VERZENIO, Nubeqa, Enhertu, LYNPARZA, TECVAYLI, MONOFERRIC.
Industry payments across AZ — which companies pay providers there.
